Simplex Trading
NKTR icon

Simplex Trading’s Nektar Therapeutics NKTR Stock Holding History

Simplex Trading’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Buy
62,100
+57,800
+1,344% +$4.23M ﹤0.01% 1305
2026
Q1 		$309K Sell
4,300
-5,700
-57% -$325K ﹤0.01% 3795
2025
Q4 		$423K Sell
10,000
-90,600
-90% -$5.07M ﹤0.01% 3468
2025
Q3 		$5.72M Sell
100,600
-107,100
-52% -$3.54M ﹤0.01% 1346
2025
Q2 		$5.37M Buy
207,700
+202,087
+3,600% +$2.27M ﹤0.01% 1288
2025
Q1 		$57K Buy
+5,613
New +$73.3K ﹤0.01% 5632
2024
Q4 		– Sell
-260
Closed -$5K – 9260
2024
Q3 		$5K Sell
260
-147
-36% -$2.8K ﹤0.01% 7632
2024
Q2 		$7K Buy
407
+74
+22% +$1.56K ﹤0.01% 7683
2024
Q1 		$4K Buy
+333
New +$3.49K ﹤0.01% 8142
2023
Q4 		– Sell
-987
Closed -$8K – 9476
2023
Q3 		$8K Buy
987
+60
+6% +$578 ﹤0.01% 7339
2023
Q2 		$7K Buy
+927
New +$9.88K ﹤0.01% 7697
2023
Q1 		– Sell
-333
Closed -$11K – 9769
2022
Q4 		$11K Sell
333
-467
-58% -$22.6K ﹤0.01% 7461
2022
Q3 		$38K Sell
800
-1,333
-62% -$79.3K ﹤0.01% 6795
2022
Q2 		$121K Sell
2,133
-48,180
-96% -$3.04M ﹤0.01% 5299
2022
Q1 		$4.07M Buy
50,313
+48,386
+2,511% +$7.16M ﹤0.01% 1424
2021
Q4 		$390K Buy
1,927
+774
+67% +$168K ﹤0.01% 4166
2021
Q3 		$303K Hold
1,153
– – ﹤0.01% 4894
2021
Q2 		$296K Buy
1,153
+1,145
+14,313% +$317K ﹤0.01% 5010
2021
Q1 		$246K Sell
8
-27
-77% -$8.4K ﹤0.01% 4429
2020
Q4 		$901K Sell
35
-11
-24% -$2.84K ﹤0.01% 2702
2020
Q3 		$1.16M Sell
46
-1
-2% -$315 ﹤0.01% 2060
2020
Q2 		$1.65M Sell
47
-3
-6% -$936 ﹤0.01% 1672
2020
Q1 		$1.35M Sell
50
-23
-32% -$7.11K ﹤0.01% 1614
2019
Q4 		$2.35M Sell
73
-25
-26% -$7.25K 0.01% 1337
2019
Q3 		$2.67M Buy
98
+53
+118% +$19.4K 0.01% 1102
2019
Q2 		$2.41M Buy
45
+9
+25% +$4.51K 0.01% 1169
2019
Q1 		$1.83M Buy
36
+18
+100% +$10.7K 0.01% 1439
2018
Q4 		$887K Sell
18
-26
-59% -$15.7K ﹤0.01% 1724
2018
Q3 		$4.07M Sell
44
-3
-6% -$2.56K 0.01% 742
2018
Q2 		$3.47M Buy
47
+40
+571% +$46.1K 0.01% 763
2018
Q1 		$51K Sell
7
-27
-79% -$34.8K ﹤0.01% 2419
2017
Q4 		$40K Buy
34
+23
+209% +$13.6K ﹤0.01% 2656
2017
Q3 		$9K Sell
11
-17
-61% -$5.32K ﹤0.01% 3876
2017
Q2 		$16K Sell
28
-26
-48% -$7.51K ﹤0.01% 3531
2017
Q1 		$13K Buy
54
+24
+80% +$5.39K ﹤0.01% 3716
2016
Q4 		$48K Buy
30
+25
+500% +$5.08K ﹤0.01% 2205
2016
Q3 		$9K Hold
5
– – ﹤0.01% 3701
2016
Q2 		$2K Buy
5
+2
+67% +$447 ﹤0.01% 4968
2016
Q1 		$2K Buy
+3
New +$576 ﹤0.01% 4763
2015
Q4 		– Sell
-4
Closed -$3K – 5891
2015
Q3 		$3K Hold
4
– – ﹤0.01% 4380
2015
Q2 		$2K Sell
4
-6
-60% -$1.03K ﹤0.01% 4312
2015
Q1 		$17K Sell
10
-7
-41% -$1.44K ﹤0.01% 2465
2014
Q4 		$29K Buy
+17
New +$3.63K ﹤0.01% 1775

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's NKTR Position: Q2 2026 in Review

Simplex Trading increased its Nektar Therapeutics (NKTR) stake by 151% in Q2 2026, buying an estimated $632K and bringing the position to 14,357 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Simplex Trading first reported a position in NKTR in Q4 2014 and has held it in 42 quarters since. The position peaked at $4.35M in Q3 2025. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Simplex Trading held 14,357 shares of Nektar Therapeutics worth $1M as of Q2 2026.
  • Simplex Trading bought 8,635 Nektar Therapeutics shares in Q2 2026, an estimated $632K.
  • Nektar Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2772 holding.
  • Simplex Trading first reported a position in Nektar Therapeutics in Q4 2014 and has held it in 42 quarters since.
  • Simplex Trading's Nektar Therapeutics position peaked at $4.35M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.